Osiris Therapeutics , Nasdaq: OSIR
Developing stem cell therapies for inflammatory, orthopedic and cardiovascular disorders.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
OSIR
Developing stem cell therapies for inflammatory, orthopedic and cardiovascular disorders.
| IPO Data | |
|---|---|
| IPO File Date | 05/12/2006 |
| Offer Price | $11.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 3.5 |
| Deal Size ($mm) | $39 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 08/03/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $39 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Baltimore, MD, United States |
| Founded | 1992 |
| Employees at IPO | n/a |
| Website www.OsirisTx.com | |
IPO News for Osiris Therapeutics
Osiris Therapeutics (OSIR) Performance
